Baird Starts Twist Bioscience (TWST) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Cowen Starts Twist Bioscience (TWST) at Outperform
November 26, 2018 5:33 AM ESTCowen analyst Doug Schenkel initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Outperform rating.
The analyst comments "TWST has built a scalable commercial platform to industrialize the synthetic engineering of DNA. TWST's unique ability to manufacture DNA cheaply and at scale... More
JPMorgan Starts Twist Bioscience (TWST) at Neutral
November 26, 2018 3:51 AM ESTJPMorgan analyst Tycho Peterson initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Neutral rating and a price target of $27.00.
The analyst views the business favorably as the company is a market leader in "an increasingly attractive niche" but comes out sidelined... More
